Open AccessMCC 'tardy' as couple suffer Mefliam 'nightmare'.
Author(s) -
Chris Bateman
Publication year - 2009
Publication title -
south african medical journal = suid-afrikaanse tydskrif vir geneeskunde
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 57
ISSN - 0256-9574
DOI - 10.7196/samj.3476
The Medicines Control Council (MCC) took 20 months to respond to an urgent Cipla-Medpro application to include vital new safety information in their generic antimalarial tablet Mefliam packaging, forcing the drug company to go ahead regardless.Now a middle-aged KwaZulu-Natal couple are suing Cipla for over R1 million after allegedly suffering years of anxiety, insomnia, depression and income loss - which they claim is a result of taking Mefliam with inadequate package warnings.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom